Nociceptin Receptor Is Overexpressed in Non-Small Cell Lung Cancer and Predicts Poor Prognosis

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00235
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

SCUBE3 Overexpression Predicts Poor Prognosis in Non-Small Cell Lung Cancer

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2013English

Overexpressed LAPTM4B-35 Is a Risk Factor for Cancer Recurrence and Poor Prognosis in Non-Small-Cell Lung Cancer

Oncotarget
Oncology
2016English

Low Level of 5-Hydroxymethylcytosine Predicts Poor Prognosis in Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2016English

Identification of a Novel lncRNA GABPB1‑IT1 That Is Downregulated and Predicts a Poor Prognosis in Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

A Chromosomal Passenger Complex Protein Signature Model Predicts Poor Prognosis For non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2015English

LINK‑A lncRNA Is Upregulated in Metastatic Non‑small Cell Lung Cancer and Is Associated With Poor Prognosis

Oncology Letters
Cancer ResearchOncology
2019English

Upregulated Expression of miR-421 Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer

Cancer Management and Research
Oncology
2018English

Reduced Expression of FADS1 Predicts Worse Prognosis in Non-Small-Cell Lung Cancer

Journal of Cancer
Oncology
2016English

MARCH8 Is Associated With Poor Prognosis in Non-Small Cell Lung Cancers Patients

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy